Kenneth J. Smith, MD, MS, from the University of Pittsburgh, responds to our questions about his research on a potential universal flu vaccine for older adults.
Dr Gregory Poland, from Mayo Clinic, Rochester, speaks about influenza vaccination in the elderly, how the approval of baloxavir marboxil will impact that patient population, and more.
Shane Crotty, PhD, from the La Jolla Institute for Immunology, talks about his discovery of the Tfh pathway and how it has affected the development of vaccines.
Shane Crotty, PhD, from the La Jolla Institute for Immunology, talks about his discovery of the Tfh pathway and how it has affected the development of vaccines.
Dr Joseph Bocchini, president of the National Foundation for Infectious Diseases, discusses influenza vaccination, the 2018-2019 season, common misconceptions about the vaccine, and more.
Sarah Gilbert from the University of Oxford answers our questions about her research on an influenza vaccine that targets cellular immunity for adults aged 65 years and older.
Dimitri Diavatopoulos, PhD, from the Radboud Center for Infectious Diseases in the Netherlands, answers our questions about controlling pertussis incidence worldwide.
Sammy Saab, MD, MPH, from the Ronald Reagan UCLA Medical Center explains the potentially deadly consequences of hepatitis B reactivation in patients being treated for hepatitis C, and why screening for...
